2003
DOI: 10.1038/nbt0703-717
|View full text |Cite
|
Sign up to set email alerts
|

UK biotech sector loses flagship PowderJect to Chiron

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0

Year Published

2003
2003
2015
2015

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 0 publications
0
6
0
Order By: Relevance
“…Microfluidics is another strong driving force for the research on the dynamics of fluids on structured substrates. Shrinking standard laboratory setups to a lab-on-a-chip promises huge cost reduction and speed-up [17,18]. Open microfluidic systems, i.e., with free liquid-vapor or liquid-liquid interfaces, may provide various advantages such as reduced friction, better accessibility of the reactants, and reduced risk of clogging by solute particles [19,20,21,22].…”
Section: Introductionmentioning
confidence: 99%
“…Microfluidics is another strong driving force for the research on the dynamics of fluids on structured substrates. Shrinking standard laboratory setups to a lab-on-a-chip promises huge cost reduction and speed-up [17,18]. Open microfluidic systems, i.e., with free liquid-vapor or liquid-liquid interfaces, may provide various advantages such as reduced friction, better accessibility of the reactants, and reduced risk of clogging by solute particles [19,20,21,22].…”
Section: Introductionmentioning
confidence: 99%
“…These microfluidic devices do not only allow for cheap mass production but they can operate with much smaller quantities of reactants and reaction products than standard laboratory equipments. This is particularly important for solutions containing rare and expensive substances, such as certain biological materials, and for toxic or explosive components [2]. Even though most microfluidic devices available today have micron sized channels, further miniaturization is leading towards the nano-scale [2,3].…”
Section: Introductionmentioning
confidence: 99%
“…This is particularly important for solutions containing rare and expensive substances, such as certain biological materials, and for toxic or explosive components [2]. Even though most microfluidic devices available today have micron sized channels, further miniaturization is leading towards the nano-scale [2,3]. Besides meeting technical challenges, new § To whom correspondence should be addressed theoretical concepts are needed to understand the basic physical processes underlying this new technology [4,5,6].…”
Section: Introductionmentioning
confidence: 99%
“…The PMED ® (Chiron Corporation) device, formerly known as PowderJect ® [302] has been reported to successfully deliver vaccines [303,304], lidocaine [305] and testosterone [306]. Dry powder formulations are generally more stable than solutions and may negate the need for the 'cold chain' to be maintained when using vaccines, for example.…”
Section: Jet Injectionmentioning
confidence: 99%